Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
금요일, 8월 28

Propanc Biopharma Inc

PPCBNASDAQ
Trade with Public
Trade with Public
$1.35
-0.88-39.46%
가까이에: Aug 28, 5:00 PM EST
$1.36
0.010.74%
시간외: 4:47 PM EST
PRO
변동 이유?:Propanc Biopharma shares are trading higher after the company announced pre...
개요뉴스실적 전망재무심리비교주식 보고서

Propanc Biopharma Financials

Propanc Biopharma (PPCB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Propanc Biopharma Q3 EPS $(0.28) Up From $(12.50) YoY

Propanc Biopharma (NASDAQ:PPCB) reported quarterly losses of $(0.28) per share. This is a 97.76 percent increase over losses of $(12.50) per share from the same period last year.
Benzinga Newsdesk

PRO
Propanc Biopharma Q2 EPS $(0.30) Up From $(32.23) YoY

Propanc Biopharma (NASDAQ:PPCB) reported quarterly losses of $(0.30) per share. This is a 99.07 percent increase over losses of $(32.23) per share from the same period last year.
Benzinga Newsdesk

PRO
Propanc Biopharma Q1 2025 EPS $(0.39) Up From $(35.97) YoY

Benzinga Newsdesk

Crude Oil Moves Higher; US Homebuilder Sentiment Declines In August

Avi Kapoor

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved